Xenopus laevis Toxicity Assay
Creative Biolabs is at the forefront of scientific innovation, offering a wide range of cutting-edge services in the field of neuroscience. One of our key areas of expertise lies in the development and application of Xenopus laevis toxicity assays, which play a crucial role in evaluating the potential neurotoxic effects of various substances. With over 20 years of experience in the industry, our team of highly skilled biological experts combines their knowledge and expertise to deliver exceptional services that meet the diverse needs of our clients.
Xenopus laevis Teratogenesis Assay (FETAX)
The Xenopus laevis Teratogenesis Assay, also known as FETAX (Frog Embryo Teratogenesis Assay-Xenopus), is a well-established and widely used method for assessing the toxic effects of chemical compounds on early vertebrate development. This assay utilizes the African clawed frog, Xenopus laevis, as a model organism due to its physiological and developmental similarities to humans. FETAX has proven to be a valuable tool in neurotoxicity testing, providing crucial insights into the potential hazards of substances on the nervous system.
The FETAX assay involves exposing Xenopus laevis embryos to test compounds during their early developmental stages. The embryos are typically obtained from in vitro fertilization and are maintained in a controlled environment throughout the assay. Various endpoints are evaluated, including mortality, malformations, and developmental abnormalities, allowing for a comprehensive assessment of the compound's toxicity.
Figure 1: FETAX Assay in Drug development with Xenopus laevis. (Saide, 2020)
FETAX Workflow
The Xenopus laevis Toxicity Assay follows a well-defined workflow, ensuring standardized and reproducible results. The key steps involved in the assay are as follows:
Applications
The Xenopus laevis toxicity assay has a wide range of applications in the field of toxicology and drug discovery. Here are some key areas where this assay has proven to be invaluable:
The FETAX assay allows researchers to evaluate the potential teratogenic effects of chemical compounds. By exposing Xenopus laevis embryos to different concentrations of a test compound, researchers can determine its impact on embryonic development. This information is crucial for identifying compounds that may pose risks to human development and reproductive health.
The FETAX assay is also employed in drug screening programs to evaluate the potential toxicity of candidate compounds during early stages of drug development. By assessing the effects of compounds on embryonic development, researchers can identify potential safety concerns and prioritize compounds with favorable toxicological profiles for further investigation.
In addition to assessing toxicity, the FETAX assay can provide valuable insights into the mechanism of action of the tested substances. By observing the developmental defects and abnormalities caused by the chemicals, researchers can gain a better understanding of how these substances interfere with normal development processes.
Please feel free to contact us for more about our Xenopus laevis models related services.
Reference
- Saide, Katy, and Grant N. Wheeler. "In vivo assessment of drug-induced hepatotoxicity using Xenopus embryos." Cold Spring Harbor Protocols 2020.11 (2020): pdb-prot106096.
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Tau Antisense Oligonucleotide (Cat#: NV-2106-P29)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
